Skip to main content
. 2022 Feb 26;22:157. doi: 10.1186/s12877-022-02844-8

Table 3.

Patients’ characteristics, comorbidities and antihypertensives medications according to change in blood pressure to orthostatic position

NOR
n = 308
OH
n = 104
OHT
n = 118
p
overall
p
NOR vs OHT
p
NOR vs OH
p
OH vs OHT
Male sex 111 (36) 43 (41.3) 25 (21.2) 0.003 0.003 0.333 0.001
Age (year) 83.0 ± 5.1 81.8 ± 5.3 83.9 ± 4.7 0.012 0.312 0.14 0.009
Hypertension 218 (70.7) 79 (76) 90 (76.3) 0.392
Diabetes mellitus 67 (21.7) 27 (26) 38 (32.2) 0.08 0.025 0.377 0.308
Heart failure 53 (17.2) 15 (14.4) 12 (10.2) 0.188
Vascular disease 55 (17.8) 19 (18.2) 12 (10.2) 0.018 0.042 0.163 0.005
  -Stroke 19 (6.2) 7 (6.7) 6 (5.1) 0.128
  -Peripheral arterial disease 35 (11.4) 13 (12.5) 6 (5.1) 0.867
  -Coronary heart disease 10 (3.2) 8 (7.7) 4 (3.4) 0.109 0.049 0.755 0.049
  -Carotid stenosis 34 (11) 12 (11.5) 16 (13.6) 0.13
Atrial fibrillation 63 (20.4) 23 (22.1) 25 (21.2) 0.935
Chronic kidney disease 90 (29.2) 38 (36.5) 23 (19.5) 0.768
eGFR CKD-EPI (mL/min) 66.5 ± 19.6 62.7 ± 19.8 65.9 ± 22.3 0.26
Treatment for hypertension 236 (76.6) 75 (72.1) 90 (76.3) 0.641
Antihypertensive drugs per patient 0.443
  -1 84 (27.3) 29 (27.9) 40 (33.9)
  -2 84 (27.3) 19 (18.3) 29 (24.6)
  -3 or more 65 (21.1) 26 (25) 22 (18.6)
Type of antihypertensive medications
  -ACEi/ARB 131 (42.5) 39 (37.5) 53 (44.9) 0.519
  -CCB 80 (25.9) 30 (28.8) 27 (22.9) 0.597
  -ß-blockers 109 (35.5) 37 (35.6) 37 (31.4) 0.703
  -Diuretics 105 (34.1) 29 (27.9) 34 (28.8) 0.547
  -Centrally-acting antihypertensive agents 17 (5.5) 5 (4.8) 14 (11.9) 0.044 0.024 0.78 0.061
  -⍺-blockers 27 (8.7) 10 (9.6) 7 (5.9) 0.551

Results are expressed as mean ± SD or n (%). NOR Normal orthostatic response, OH Orthostatic hypotension, OHT Orthostatic hypertension, eGFR CKD-EPI estimated Glomerular Filtration Rate by CKD-EPI Formula, ACEi/ARB Angiotensin-Converting Enzyme inhibitors/Angiotensin II Receptor Blockers, CCB Calcium-Channel Blockers;